nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Jaundice cholestatic—Lovastatin—atherosclerosis	0.0214	0.022	CcSEcCtD
Cefprozil—Jaundice cholestatic—Simvastatin—atherosclerosis	0.0201	0.0206	CcSEcCtD
Cefprozil—Jaundice cholestatic—Niacin—atherosclerosis	0.0184	0.0189	CcSEcCtD
Cefprozil—Jaundice cholestatic—Pravastatin—atherosclerosis	0.0181	0.0186	CcSEcCtD
Cefprozil—Vaginal inflammation—Niacin—atherosclerosis	0.0162	0.0166	CcSEcCtD
Cefprozil—Vaginal infection—Niacin—atherosclerosis	0.0153	0.0157	CcSEcCtD
Cefprozil—Haemolytic anaemia—Lovastatin—atherosclerosis	0.0151	0.0156	CcSEcCtD
Cefprozil—Haemolytic anaemia—Simvastatin—atherosclerosis	0.0142	0.0146	CcSEcCtD
Cefprozil—Haemolytic anaemia—Pravastatin—atherosclerosis	0.0128	0.0132	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.0123	0.0127	CcSEcCtD
Cefprozil—Eosinophilia—Lovastatin—atherosclerosis	0.0117	0.012	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.0115	0.0118	CcSEcCtD
Cefprozil—Eosinophilia—Ezetimibe—atherosclerosis	0.0115	0.0118	CcSEcCtD
Cefprozil—Pharyngitis—Rosuvastatin—atherosclerosis	0.0111	0.0114	CcSEcCtD
Cefprozil—Eosinophilia—Simvastatin—atherosclerosis	0.0109	0.0113	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.0104	0.0107	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.0104	0.0107	CcSEcCtD
Cefprozil—Eosinophilia—Pravastatin—atherosclerosis	0.0099	0.0102	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00977	0.01	CcSEcCtD
Cefprozil—Pharyngitis—Ezetimibe—atherosclerosis	0.00921	0.00947	CcSEcCtD
Cefprozil—Erythema multiforme—Lovastatin—atherosclerosis	0.00895	0.0092	CcSEcCtD
Cefprozil—Angioedema—Rosuvastatin—atherosclerosis	0.00888	0.00913	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00884	0.00909	CcSEcCtD
Cefprozil—Erythema multiforme—Ezetimibe—atherosclerosis	0.00877	0.00902	CcSEcCtD
Cefprozil—Erythema multiforme—Simvastatin—atherosclerosis	0.00837	0.0086	CcSEcCtD
Cefprozil—Haemoglobin—Niacin—atherosclerosis	0.00817	0.0084	CcSEcCtD
Cefprozil—Haemorrhage—Niacin—atherosclerosis	0.00813	0.00836	CcSEcCtD
Cefprozil—Erythema—Ezetimibe—atherosclerosis	0.00808	0.00831	CcSEcCtD
Cefprozil—Confusional state—Rosuvastatin—atherosclerosis	0.008	0.00822	CcSEcCtD
Cefprozil—Pharyngitis—Pravastatin—atherosclerosis	0.00794	0.00816	CcSEcCtD
Cefprozil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00777	0.00798	CcSEcCtD
Cefprozil—Erythema—Simvastatin—atherosclerosis	0.0077	0.00792	CcSEcCtD
Cefprozil—Erythema multiforme—Pravastatin—atherosclerosis	0.00757	0.00778	CcSEcCtD
Cefprozil—Angioedema—Lovastatin—atherosclerosis	0.00753	0.00774	CcSEcCtD
Cefprozil—Angioedema—Ezetimibe—atherosclerosis	0.00738	0.00759	CcSEcCtD
Cefprozil—Insomnia—Rosuvastatin—atherosclerosis	0.00717	0.00738	CcSEcCtD
Cefprozil—Erythema—Niacin—atherosclerosis	0.00707	0.00727	CcSEcCtD
Cefprozil—Angioedema—Simvastatin—atherosclerosis	0.00704	0.00724	CcSEcCtD
Cefprozil—Tension—Niacin—atherosclerosis	0.00694	0.00714	CcSEcCtD
Cefprozil—Nervousness—Niacin—atherosclerosis	0.00687	0.00706	CcSEcCtD
Cefprozil—Tension—Pravastatin—atherosclerosis	0.00684	0.00703	CcSEcCtD
Cefprozil—Pain—Rosuvastatin—atherosclerosis	0.00678	0.00697	CcSEcCtD
Cefprozil—Confusional state—Lovastatin—atherosclerosis	0.00678	0.00697	CcSEcCtD
Cefprozil—Nervousness—Pravastatin—atherosclerosis	0.00676	0.00696	CcSEcCtD
Cefprozil—Anaphylactic shock—Lovastatin—atherosclerosis	0.00672	0.00691	CcSEcCtD
Cefprozil—Confusional state—Ezetimibe—atherosclerosis	0.00665	0.00684	CcSEcCtD
Cefprozil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00659	0.00678	CcSEcCtD
Cefprozil—Thrombocytopenia—Lovastatin—atherosclerosis	0.00658	0.00677	CcSEcCtD
Cefprozil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00654	0.00672	CcSEcCtD
Cefprozil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00649	0.00667	CcSEcCtD
Cefprozil—Angioedema—Niacin—atherosclerosis	0.00646	0.00665	CcSEcCtD
Cefprozil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00646	0.00664	CcSEcCtD
Cefprozil—Cefdinir—MPO—atherosclerosis	0.00645	0.236	CrCbGaD
Cefprozil—Cefaclor—MPO—atherosclerosis	0.00639	0.234	CrCbGaD
Cefprozil—Angioedema—Pravastatin—atherosclerosis	0.00636	0.00654	CcSEcCtD
Cefprozil—Confusional state—Simvastatin—atherosclerosis	0.00634	0.00652	CcSEcCtD
Cefprozil—Urticaria—Rosuvastatin—atherosclerosis	0.0063	0.00648	CcSEcCtD
Cefprozil—Anaphylactic shock—Simvastatin—atherosclerosis	0.00629	0.00646	CcSEcCtD
Cefprozil—Abdominal pain—Rosuvastatin—atherosclerosis	0.00627	0.00645	CcSEcCtD
Cefprozil—Thrombocytopenia—Simvastatin—atherosclerosis	0.00616	0.00633	CcSEcCtD
Cefprozil—Insomnia—Lovastatin—atherosclerosis	0.00608	0.00625	CcSEcCtD
Cefprozil—Insomnia—Ezetimibe—atherosclerosis	0.00596	0.00613	CcSEcCtD
Cefprozil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00584	0.00601	CcSEcCtD
Cefprozil—Anaphylactic shock—Niacin—atherosclerosis	0.00577	0.00594	CcSEcCtD
Cefprozil—Pain—Lovastatin—atherosclerosis	0.00575	0.00591	CcSEcCtD
Cefprozil—Confusional state—Pravastatin—atherosclerosis	0.00573	0.00589	CcSEcCtD
Cefprozil—Insomnia—Simvastatin—atherosclerosis	0.00569	0.00585	CcSEcCtD
Cefprozil—Anaphylactic shock—Pravastatin—atherosclerosis	0.00568	0.00584	CcSEcCtD
Cefprozil—Pain—Ezetimibe—atherosclerosis	0.00564	0.0058	CcSEcCtD
Cefprozil—Pruritus—Rosuvastatin—atherosclerosis	0.00561	0.00577	CcSEcCtD
Cefprozil—Thrombocytopenia—Pravastatin—atherosclerosis	0.00557	0.00572	CcSEcCtD
Cefprozil—Feeling abnormal—Lovastatin—atherosclerosis	0.00554	0.0057	CcSEcCtD
Cefprozil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0055	0.00565	CcSEcCtD
Cefprozil—Feeling abnormal—Ezetimibe—atherosclerosis	0.00543	0.00559	CcSEcCtD
Cefprozil—Diarrhoea—Rosuvastatin—atherosclerosis	0.00543	0.00558	CcSEcCtD
Cefprozil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00539	0.00554	CcSEcCtD
Cefprozil—Pain—Simvastatin—atherosclerosis	0.00538	0.00553	CcSEcCtD
Cefprozil—Urticaria—Lovastatin—atherosclerosis	0.00534	0.00549	CcSEcCtD
Cefprozil—Body temperature increased—Lovastatin—atherosclerosis	0.00531	0.00546	CcSEcCtD
Cefprozil—Abdominal pain—Lovastatin—atherosclerosis	0.00531	0.00546	CcSEcCtD
Cefprozil—Dizziness—Rosuvastatin—atherosclerosis	0.00525	0.00539	CcSEcCtD
Cefprozil—Urticaria—Ezetimibe—atherosclerosis	0.00524	0.00539	CcSEcCtD
Cefprozil—Insomnia—Niacin—atherosclerosis	0.00522	0.00537	CcSEcCtD
Cefprozil—Abdominal pain—Ezetimibe—atherosclerosis	0.00521	0.00536	CcSEcCtD
Cefprozil—Body temperature increased—Ezetimibe—atherosclerosis	0.00521	0.00536	CcSEcCtD
Cefprozil—Feeling abnormal—Simvastatin—atherosclerosis	0.00518	0.00533	CcSEcCtD
Cefprozil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00514	0.00529	CcSEcCtD
Cefprozil—Insomnia—Pravastatin—atherosclerosis	0.00514	0.00529	CcSEcCtD
Cefprozil—Somnolence—Niacin—atherosclerosis	0.00513	0.00528	CcSEcCtD
Cefprozil—Rash—Rosuvastatin—atherosclerosis	0.005	0.00514	CcSEcCtD
Cefprozil—Dermatitis—Rosuvastatin—atherosclerosis	0.005	0.00514	CcSEcCtD
Cefprozil—Urticaria—Simvastatin—atherosclerosis	0.005	0.00514	CcSEcCtD
Cefprozil—Abdominal pain—Simvastatin—atherosclerosis	0.00497	0.00511	CcSEcCtD
Cefprozil—Body temperature increased—Simvastatin—atherosclerosis	0.00497	0.00511	CcSEcCtD
Cefprozil—Headache—Rosuvastatin—atherosclerosis	0.00497	0.00511	CcSEcCtD
Cefprozil—Hypersensitivity—Lovastatin—atherosclerosis	0.00495	0.00509	CcSEcCtD
Cefprozil—Pain—Niacin—atherosclerosis	0.00494	0.00508	CcSEcCtD
Cefprozil—Pain—Pravastatin—atherosclerosis	0.00486	0.005	CcSEcCtD
Cefprozil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00486	0.00499	CcSEcCtD
Cefprozil—Pruritus—Lovastatin—atherosclerosis	0.00476	0.00489	CcSEcCtD
Cefprozil—Gastrointestinal pain—Niacin—atherosclerosis	0.00472	0.00485	CcSEcCtD
Cefprozil—Nausea—Rosuvastatin—atherosclerosis	0.00471	0.00484	CcSEcCtD
Cefprozil—Feeling abnormal—Pravastatin—atherosclerosis	0.00468	0.00482	CcSEcCtD
Cefprozil—Pruritus—Ezetimibe—atherosclerosis	0.00466	0.0048	CcSEcCtD
Cefprozil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00465	0.00478	CcSEcCtD
Cefprozil—Hypersensitivity—Simvastatin—atherosclerosis	0.00463	0.00476	CcSEcCtD
Cefprozil—Diarrhoea—Lovastatin—atherosclerosis	0.0046	0.00473	CcSEcCtD
Cefprozil—Urticaria—Niacin—atherosclerosis	0.00459	0.00472	CcSEcCtD
Cefprozil—Abdominal pain—Niacin—atherosclerosis	0.00456	0.00469	CcSEcCtD
Cefprozil—Body temperature increased—Niacin—atherosclerosis	0.00456	0.00469	CcSEcCtD
Cefprozil—Urticaria—Pravastatin—atherosclerosis	0.00452	0.00464	CcSEcCtD
Cefprozil—Diarrhoea—Ezetimibe—atherosclerosis	0.00451	0.00464	CcSEcCtD
Cefprozil—Body temperature increased—Pravastatin—atherosclerosis	0.00449	0.00462	CcSEcCtD
Cefprozil—Abdominal pain—Pravastatin—atherosclerosis	0.00449	0.00462	CcSEcCtD
Cefprozil—Pruritus—Simvastatin—atherosclerosis	0.00445	0.00457	CcSEcCtD
Cefprozil—Dizziness—Lovastatin—atherosclerosis	0.00445	0.00457	CcSEcCtD
Cefprozil—Dizziness—Ezetimibe—atherosclerosis	0.00436	0.00448	CcSEcCtD
Cefprozil—Diarrhoea—Simvastatin—atherosclerosis	0.0043	0.00442	CcSEcCtD
Cefprozil—Vomiting—Lovastatin—atherosclerosis	0.00427	0.00439	CcSEcCtD
Cefprozil—Hypersensitivity—Niacin—atherosclerosis	0.00425	0.00437	CcSEcCtD
Cefprozil—Rash—Lovastatin—atherosclerosis	0.00424	0.00436	CcSEcCtD
Cefprozil—Dermatitis—Lovastatin—atherosclerosis	0.00423	0.00435	CcSEcCtD
Cefprozil—Headache—Lovastatin—atherosclerosis	0.00421	0.00433	CcSEcCtD
Cefprozil—Vomiting—Ezetimibe—atherosclerosis	0.00419	0.00431	CcSEcCtD
Cefprozil—Hypersensitivity—Pravastatin—atherosclerosis	0.00419	0.00431	CcSEcCtD
Cefprozil—Cefpiramide—ALB—atherosclerosis	0.00416	0.152	CrCbGaD
Cefprozil—Dizziness—Simvastatin—atherosclerosis	0.00416	0.00427	CcSEcCtD
Cefprozil—Rash—Ezetimibe—atherosclerosis	0.00416	0.00427	CcSEcCtD
Cefprozil—Dermatitis—Ezetimibe—atherosclerosis	0.00415	0.00427	CcSEcCtD
Cefprozil—Headache—Ezetimibe—atherosclerosis	0.00413	0.00425	CcSEcCtD
Cefprozil—Pruritus—Niacin—atherosclerosis	0.00408	0.0042	CcSEcCtD
Cefprozil—Pruritus—Pravastatin—atherosclerosis	0.00402	0.00413	CcSEcCtD
Cefprozil—Vomiting—Simvastatin—atherosclerosis	0.004	0.00411	CcSEcCtD
Cefprozil—Nausea—Lovastatin—atherosclerosis	0.00399	0.00411	CcSEcCtD
Cefprozil—Rash—Simvastatin—atherosclerosis	0.00396	0.00408	CcSEcCtD
Cefprozil—Dermatitis—Simvastatin—atherosclerosis	0.00396	0.00407	CcSEcCtD
Cefprozil—Diarrhoea—Niacin—atherosclerosis	0.00395	0.00406	CcSEcCtD
Cefprozil—Headache—Simvastatin—atherosclerosis	0.00394	0.00405	CcSEcCtD
Cefprozil—Nausea—Ezetimibe—atherosclerosis	0.00392	0.00403	CcSEcCtD
Cefprozil—Diarrhoea—Pravastatin—atherosclerosis	0.00389	0.004	CcSEcCtD
Cefprozil—Dizziness—Niacin—atherosclerosis	0.00382	0.00393	CcSEcCtD
Cefprozil—Dizziness—Pravastatin—atherosclerosis	0.00376	0.00386	CcSEcCtD
Cefprozil—Nausea—Simvastatin—atherosclerosis	0.00373	0.00384	CcSEcCtD
Cefprozil—Vomiting—Niacin—atherosclerosis	0.00367	0.00377	CcSEcCtD
Cefprozil—Rash—Niacin—atherosclerosis	0.00364	0.00374	CcSEcCtD
Cefprozil—Dermatitis—Niacin—atherosclerosis	0.00364	0.00374	CcSEcCtD
Cefprozil—Cefonicid—ALB—atherosclerosis	0.00362	0.132	CrCbGaD
Cefprozil—Headache—Niacin—atherosclerosis	0.00362	0.00372	CcSEcCtD
Cefprozil—Vomiting—Pravastatin—atherosclerosis	0.00361	0.00372	CcSEcCtD
Cefprozil—Rash—Pravastatin—atherosclerosis	0.00358	0.00369	CcSEcCtD
Cefprozil—Dermatitis—Pravastatin—atherosclerosis	0.00358	0.00368	CcSEcCtD
Cefprozil—Headache—Pravastatin—atherosclerosis	0.00356	0.00366	CcSEcCtD
Cefprozil—Nausea—Niacin—atherosclerosis	0.00343	0.00353	CcSEcCtD
Cefprozil—Nausea—Pravastatin—atherosclerosis	0.00338	0.00347	CcSEcCtD
Cefprozil—Cefoperazone—ALB—atherosclerosis	0.00214	0.078	CrCbGaD
Cefprozil—Ampicillin—ALB—atherosclerosis	0.00182	0.0664	CrCbGaD
Cefprozil—Cefalotin—ALB—atherosclerosis	0.00146	0.0533	CrCbGaD
Cefprozil—Cephalexin—ALB—atherosclerosis	0.00132	0.0484	CrCbGaD
